TY - JOUR
T1 - Technologies for the bioconversion of methane into more valuable products
AU - Cantera, Sara
AU - Muñoz, Raúl
AU - Lebrero, Raquel
AU - López, Juan Carlos
AU - Rodríguez, Yadira
AU - García-Encina, Pedro Antonio
PY - 2018/4
Y1 - 2018/4
N2 - Methane, with a global warming potential twenty five times higher than that of CO 2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high retail value in the industry offers a potential cost-efficient and environmentally friendly solution for mitigating anthropogenic diluted CH 4 -laden streams. Methane bio-refinery for the production of different compounds such as ectoine, feed proteins, biofuels, bioplastics and polysaccharides, apart from new bioproducts characteristic of methanotrophic bacteria, has been recently tested in discontinuous and continuous bioreactors with promising results. This review constitutes a critical discussion about the state-of-the-art of the potential and research niches of biotechnologies applied in a CH 4 biorefinery approach.
AB - Methane, with a global warming potential twenty five times higher than that of CO 2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high retail value in the industry offers a potential cost-efficient and environmentally friendly solution for mitigating anthropogenic diluted CH 4 -laden streams. Methane bio-refinery for the production of different compounds such as ectoine, feed proteins, biofuels, bioplastics and polysaccharides, apart from new bioproducts characteristic of methanotrophic bacteria, has been recently tested in discontinuous and continuous bioreactors with promising results. This review constitutes a critical discussion about the state-of-the-art of the potential and research niches of biotechnologies applied in a CH 4 biorefinery approach.
U2 - 10.1016/j.copbio.2017.12.021
DO - 10.1016/j.copbio.2017.12.021
M3 - Article
C2 - 29316497
AN - SCOPUS:85040086611
SN - 0958-1669
VL - 50
SP - 128
EP - 135
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
ER -